BRC Consultant in Medical Oncology
Applications are invited for the position of Consultant in Medical Oncology to work at the Sutton site of The Royal Marsden NHS Foundation Trust in the Drug Development Unit (DDU).
The Royal Marsden is a world leader in cancer research, treatment and education. Together with our academic partner, The Institute of Cancer Research (ICR), we are the largest comprehensive cancer centre in Europe and the only National Institute of Health Research (NIHR) Biomedical Research Centre specialising in cancer in the UK.
The Drug Development Unit (DDU) at the Sutton campus of the ICR and The Royal Marsden is the largest in Europe, involved in early clinical trials of novel anticancer agents from pharmaceutical companies as well as agents developed at the CRUK Cancer Therapeutics Unit, which is sited on the same campus.
The DDU is supported by more than 20 research and ward nurses providing 24-hour cover for five days per week, and eleven clinical research fellows as well as data management and laboratory staff based in the CRUK Cancer Therapeutics Unit, where there is extensive expertise in pharmacokinetic and pharmacodynamic analyses within Phase I trials. In addition there is a dedicated team of (four) sample collection technicians, clinical trial coordinators (eight), data managers (ten) pharmacy staff (two) and a regulatory team (two).
The Drug Development Unit has a dedicated ward of ten in-patient beds and five day beds for patients enrolled on phase I trials. This facility – Oak Ward – was officially opened in February 2005. There are currently three consultants, Professor Johann de Bono (Director of DDU), Dr Udai Banerji (Deputy Director of DDU), and Dr Juanita Lopez.
An opportunity has arisen to join this successful team in response to patient referrals having increased 3-fold over the past three years.
You will be expected to lead clinical trials in the Drug Development Unit and in The Royal Marsden. The post is funded by the Royal Marsden/ICR BRC and by the Royal Marsden Cancer Charity. You will be expected to have a track record in early clinical trial drug development and attract peer-reviewed grant funding/fellowship and/or industry funding.
The post will involve joining the Drug Development Unit in Sutton and leading on early hypothesis-testing clinical trials. You will be expected to work with a team of laboratory-based researchers within the Cancer Biomarkers Team (led by Professor Johann de Bono) within the Centre for Molecular Pathology.
Applicants should be eligible for full registration with the General Medical Council and have membership of the Royal College of Physicians or hold equivalent qualifications. Applicants will have their CCT or be within six months of obtaining it.
For further details / informal visits contact:
Professor Johann de Bono on 020 8722 4029 or
Professor David Cunningham on 020 8661 3156
For more information and to apply for this position, please click the Apply button
Please ensure you attach a copy of your CV when submitting your application form.
Closing date: 20th October 2017